A territory-wide retrospective observational cohort study of two different types of COVID-19 vaccines and serial liver biochemistries in Hong Kong
Latest Information Update: 23 Aug 2022
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 23 Aug 2022 New trial record
- 26 Jun 2022 Results presented at The International Liver Congress 2022